Drug money saves hospital dollars?
"The jury's still out" on whether prescription drug spending prevents later hospital costs, CMS National Health Statistics Group Director Katharine Levit says at Health Affairs briefing Jan. 7. CMS report finds increase in 2001 in both drug spending and amount of hospital services used per capita (4.2% growth over 2000)...
You may also be interested in...
Inovio Pharmaceuticals has reported promising initial data from its first Phase III study of its electrical current-driven DNA plasmid-based immunotherapy, VGX-3100, in virus-associated cervical dysplasia; it is heading a small group of companies evaluating novel therapies in the condition, which often advances to cancer.
In the month ahead, a key ANDA approval could come for Viatris, while additional competition to Gilead Sciences’ Truvada for PrEP is on the way in the US following Teva and Amneal’s launches.
Sensyne obtained UK regulatory approval for its SYNE-COV machine learning algorithm to assess the long-term risks of COVID-19.